Sudarshan Pharma Industries Limited (BOM:543828)
24.06
-1.26 (-4.98%)
At close: Oct 24, 2025
BOM:543828 Revenue
Sudarshan Pharma Industries had revenue of 3.14B INR in the quarter ending September 30, 2025, with 35.52% growth. This brings the company's revenue in the last twelve months to 5.92B, up 28.92% year-over-year. In the fiscal year ending March 31, 2025, Sudarshan Pharma Industries had annual revenue of 5.05B with 8.95% growth.
Revenue (ttm)
5.92B
Revenue Growth
+28.92%
P/S Ratio
0.94
Revenue / Employee
98.74M
Employees
60
Market Cap
5.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.05B | 415.07M | 8.95% |
| Mar 31, 2024 | 4.64B | 22.10M | 0.48% |
| Mar 31, 2023 | 4.61B | 1.04B | 29.19% |
| Mar 31, 2022 | 3.57B | 1.64B | 84.52% |
| Mar 31, 2021 | 1.94B | 455.35M | 30.77% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.04T |
| State Bank of India | 3.50T |
| Larsen & Toubro | 2.69T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| ICICI Bank | 1.91T |
| Bharti Airtel | 1.84T |